These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study. Newman-Tancredi A, Cussac D, Audinot V, Pasteau V, Gavaudan S, Millan MJ. Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542 [Abstract] [Full Text] [Related]
8. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue. Scott C, Soffin EM, Hill M, Atkinson PJ, Langmead CJ, Wren PB, Faedo S, Gordon LJ, Price GW, Bromidge S, Johnson CN, Hagan JJ, Watson J. Eur J Pharmacol; 2006 Apr 24; 536(1-2):54-61. PubMed ID: 16571351 [Abstract] [Full Text] [Related]
9. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents. Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ. J Pharmacol Exp Ther; 1997 Jul 24; 282(1):181-91. PubMed ID: 9223553 [Abstract] [Full Text] [Related]
10. Magnitude of 5-HT1B and 5-HT1A receptor activation in guinea-pig and rat brain: evidence from sumatriptan dimer-mediated [35S]GTPgammaS binding responses. Dupuis DS, Perez M, Halazy S, Colpaert FC, Pauwels PJ. Brain Res Mol Brain Res; 1999 Apr 06; 67(1):107-23. PubMed ID: 10101238 [Abstract] [Full Text] [Related]
11. Characterization of dopaminergic compounds at hD2short, hD4.2 and hD4.7 receptors in agonist-stimulated [35S]GTPgammaS binding assays. Gilliland SL, Alper RH. Naunyn Schmiedebergs Arch Pharmacol; 2000 May 06; 361(5):498-504. PubMed ID: 10832603 [Abstract] [Full Text] [Related]
17. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole. Millan MJ, Cussac D, Gobert A, Lejeune F, Rivet JM, Mannoury La Cour C, Newman-Tancredi A, Peglion JL. J Pharmacol Exp Ther; 2004 Jun 06; 309(3):903-20. PubMed ID: 14978194 [Abstract] [Full Text] [Related]
18. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity. Millan MJ, Newman-Tancredi A, Rivet JM, Brocco M, Lacroix P, Audinot V, Cistarelli L, Gobert A. J Pharmacol Exp Ther; 1997 Jul 06; 282(1):132-47. PubMed ID: 9223549 [Abstract] [Full Text] [Related]
19. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors. Newman-Tancredi A, Nicolas JP, Audinot V, Gavaudan S, Verrièle L, Touzard M, Chaput C, Richard N, Millan MJ. Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug 06; 358(2):197-206. PubMed ID: 9750005 [Abstract] [Full Text] [Related]
20. Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT(1D) receptors. Audinot V, Newman-Tancredi A, Cussac D, Millan MJ. Neuropsychopharmacology; 2001 Sep 06; 25(3):410-22. PubMed ID: 11522469 [Abstract] [Full Text] [Related] Page: [Next] [New Search]